Detecting erbB2 Variations in Esophageal Cancer Patients' Blood
Author Information
Author(s): Andolfo Immacolata, Petrosino Giuseppe, Vecchione Loredana, De Antonellis Pasqualino, Capasso Mario, Montanaro Donatella, Gemei Marica, Troncone Giancarlo, Iolascon Achille, Orditura Michele, Ciardiello Fortunato, De Vita Fernando, Zollo Massimo
Primary Institution: CEINGE, Centro di Ingegneria Genetica e Biotecnologia Avanzate, Naples, Italy
Hypothesis
Can erbB2 copy number variations in plasma serve as a prognostic marker for early detection of esophageal carcinoma progression?
Conclusion
The erbB2 gene copy number variations in plasma can indicate a worse clinical outcome in esophageal cancer patients.
Supporting Evidence
- The erbB2 gene showed significant copy number variations in the plasma of patients compared to healthy controls.
- The study found an 80% sensitivity and 95% specificity for detecting erbB2 variations.
- Higher erbB2 copy numbers were associated with lower progression-free survival rates.
Takeaway
Doctors can check for changes in a gene called erbB2 in the blood of patients with esophageal cancer to see if their cancer might get worse.
Methodology
Plasma samples from 41 esophageal carcinoma patients were analyzed for erbB2 gene copy number variations using real-time PCR.
Limitations
The study had a small sample size and was conducted at a single center, which may limit the generalizability of the findings.
Participant Demographics
Patients were aged 52-74 years, with a mix of men and women.
Statistical Information
P-Value
0.001
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website